Zobrazeno 1 - 10
of 10
pro vyhledávání: '"You‐Ping Chan"'
Autor:
Grit Andersen, Rosy Eloy, Susanne Famulla, Tim Heise, Grégory Meiffren, Cyril Seroussi, Martin Gaudier, Claire Mégret, You‐Ping Chan, Olivier Soula, Matthew Riddle
Publikováno v:
Diabetes, Obesity and Metabolism. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19096cf36cfed1bbfac2360c65466891
https://doi.org/10.1111/dom.15067
https://doi.org/10.1111/dom.15067
Autor:
null Grit Andersen, null Rosy Eloy, null Susanne Famulla, null Tim Heise, null Grégory Meiffren, null Cyril Seroussi, null Martin Gaudier, null Claire Mégret, null You‐Ping Chan, null Olivier Soula, null Matthew Riddle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ed92bd5dfed53094ecd117ff0d8208e
https://doi.org/10.1111/dom.14972/v2/response1
https://doi.org/10.1111/dom.14972/v2/response1
Autor:
Claire Mégret, You-Ping Chan, Rosy Eloy, Grit Andersen, J. Hans DeVries, Grégory Meiffren, Olivier Soula, Martin Gaudier, Cyril Seroussi, Tim Heise, Susanne Famulla
Publikováno v:
Diabetes. 70
ADO09 is a co-formulation of Pram and insulin A21G developed to deliver the positive effects of Pram without additional injections. This double-blind randomized cross-over trial investigated the effects of pre-meal ADO09 vs. insulin aspart (ASP) on m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::344b58e8f9605e9d2046b5ae4726d3b5
https://doi.org/10.2337/db21-197-or
https://doi.org/10.2337/db21-197-or
Autor:
Grit Andersen, Grégory Meiffren, Susanne Famulla, Tim Heise, Aymeric Ranson, Cyril Seroussi, Rosy Eloy, Martin Gaudier, Richard Charvet, You‐Ping Chan, Olivier Soula, J. Hans DeVries
Publikováno v:
Diabetes, Obesity and Metabolism. 23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09dbf8fcd5c4721ef0ea23873b3b6cee
https://doi.org/10.1111/dom.14378
https://doi.org/10.1111/dom.14378
Autor:
Grégory Meiffren, Grit Andersen, J. Hans DeVries, Olivier Soula, Susanne Famulla, Richard Charvet, Martin Gaudier, Tim Heise, Aymeric Ranson, Rosy Eloy, You-Ping Chan, Cyril Seroussi
Publikováno v:
Diabetes, obesity & metabolism, 23(4), 961-970. Wiley-Blackwell
Aim: To compare the safety, pharmacokinetics and pharmacodynamics of ADO09 with insulin lispro (Lispro) and separate subcutaneous injections of human insulin and pramlintide (Ins&Pram) in 24 subjects with type 1 diabetes. Methods: At three dosing vis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7bd276e57e5cbc9a4303b6b2f02c80d
https://pubmed.ncbi.nlm.nih.gov/33336850
https://pubmed.ncbi.nlm.nih.gov/33336850
Autor:
Martin Gaudier, Susanne Famulla, Cyril Seroussi, Rosy Eloy, Grégory Meiffren, Grit Andersen, Richard Charvet, Olivier Soula, Tim Heise, J. Hans DeVries, Aymeric Ranson, You-Ping Chan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53b092835fde852201dee76db3559eee
https://doi.org/10.1111/dom.14302/v2/response1
https://doi.org/10.1111/dom.14302/v2/response1
Autor:
Tim Heise, J. Hans DeVries, Claire Mégret, Grégory Meiffren, Martin Gaudier, Rosy Eloy, Cyril Seroussi, Olivier Soula, Susanne Famulla, You-Ping Chan, Grit Andersen
Publikováno v:
Diabetes. 69
ADO09 is a co-formulation of PRAM and insulin A21G developed to leverage the beneficial effects of PRAM on post-prandial glucose without additional injections. This double-blind randomized cross-over trial studied pre-meal ADO09 vs. Novolog® over 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c6f5a95073baba46b671a1331666759
https://doi.org/10.2337/db20-112-lb
https://doi.org/10.2337/db20-112-lb
Publikováno v:
Analytical and Bioanalytical Chemistry
Analytical and Bioanalytical Chemistry, Springer Verlag, 2014, 405 (16), pp.5369-5379. ⟨10.1007/s00216-013-6972-4⟩
Analytical and Bioanalytical Chemistry, Springer Verlag, 2014, 405 (16), pp.5369-5379. ⟨10.1007/s00216-013-6972-4⟩
In this work, Taylor dispersion analysis and capillary electrophoresis were used to characterize the size and charge of polymeric drug delivery nanogels based on polyglutamate chains grafted with hydrophobic groups of vitamin E. The hydrophobic vitam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd319fae27721bfae8565e1355125de0
https://pubmed.ncbi.nlm.nih.gov/23624952
https://pubmed.ncbi.nlm.nih.gov/23624952
Publikováno v:
Expert opinion on drug delivery. 4(4)
The polymer-based Medusa system (Flamel Technologies) has been designed for slow release of therapeutic proteins and peptides. The Medusa II consists of a poly L-glutamate backbone grafted with hydrophobic alpha-tocopherol molecules, creating a collo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ae5611c8ce68ca2d72acea6a5923849
https://pubmed.ncbi.nlm.nih.gov/17683256
https://pubmed.ncbi.nlm.nih.gov/17683256
Publikováno v:
NanoBiotechnology. 1:317-318
• Basulin® is the only once-a-day human insulin with a proof of efficacy in human clinical trials. • Basulin has demonstrated a good safety and tolerability and confirmed the 24 hours efficacy in Phase IIa during 14 days with 20 patients. • Ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f7e3ad29c119836e3d4df12e3249c9c
https://doi.org/10.1007/s12030-005-0061-5
https://doi.org/10.1007/s12030-005-0061-5